SCHEMBL10705560

SCHEMBL10705560

C=C1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@]2(C)C1=CC(=O)CC2CCl

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 7/20 0.49
▸ NR3C1 P04150 7/20 0.49
▸ PGR P06401 7/20 0.49
▸ AR P10275 6/20 0.49
▸ SMN1; SMN2 Q16637 5/20 0.49
▸ NPSR1 Q6W5P4 4/20 0.49
▸ MAPK1 P28482 3/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ CHRM2 P08172 3/20 0.49
▸ HIF1A Q16665 3/20 0.49
▸ CHRM1 P11229 2/20 0.49
▸ USP2 O75604 2/20 0.49
▸ ADORA3 P0DMS8 2/20 0.49
▸ THRB P10828 1/20 0.49
▸ TBXA2R P21731 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ ADRA1A P35348 1/20 0.49
▸ LMNA P02545 6/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10705553 1.00 CYP3A4 (0.49) CYP3A4NR3C1PGRARSMN1; SMN2
SCHEMBL10707927 0.92 CYP3A4 (0.44) CYP3A4NR3C1PGRARSMN1; SMN2
SCHEMBL10711533 0.90 NR3C1 (0.48) CYP3A4NR3C1PGRARSMN1; SMN2
SCHEMBL10705817 0.90 CYP3A4 (0.53) CYP3A4NR3C1PGRARSMN1; SMN2
SCHEMBL10707897 0.88 CYP3A4 (0.40) CYP3A4NR3C1PGRARSMN1; SMN2
SCHEMBL10704042 0.88 CYP3A4 (0.56) CYP3A4NR3C1PGRARSMN1; SMN2
SCHEMBL10705824 0.86 CYP3A4 (0.42) CYP3A4NR3C1PGRARSMN1; SMN2
SCHEMBL853001 0.82 LMNA (0.67) CYP3A4NR3C1PGRARSMN1; SMN2
SCHEMBL9622429 0.82 LMNA (0.67) CYP3A4NR3C1PGRARSMN1; SMN2
SCHEMBL13941337 0.82 LMNA (0.67) CYP3A4NR3C1PGRARSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0104549-B1 AZOLYL BUTANOLES BAYER AG (DE) 1987-07-29 — — EP claimed
EP-0104549-A2 Azolyl butanoles BAYER AG (DE) 1984-04-04 — — EP claimed
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP disclosed
EP-0104549-B1 AZOLYL BUTANOLES BAYER AG (DE) 1987-07-29 — — EP disclosed
EP-0104549-B1 AZOLYL BUTANOLES BAYER AG (DE) 1987-07-29 — — EP disclosed
US-4670427-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US disclosed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP disclosed
EP-0104549-A2 Azolyl butanoles BAYER AG (DE) 1984-04-04 — — EP disclosed
EP-0104549-A2 Azolyl butanoles BAYER AG (DE) 1984-04-04 — — EP disclosed
EP-0104549-A2 Azolyl butanoles BAYER AG (DE) 1984-04-04 — — EP disclosed
Send feedback